'Mini-brains' model myelin damage and regeneration, offering new tool for MS drug testing

AI Summary

Researchers have developed 3D “mini-brain” models that reproduce myelin damage and regeneration, with the aim of improving drug testing for multiple sclerosis. The work could provide a new tool for studying treatments for an autoimmune disease affecting nearly three million people worldwide.

Researchers have developed 3D "mini-brains" they hope will help speed up the search for much-needed drug treatments for multiple sclerosis (MS), an autoimmune condition affecting almost 3 million people worldwide. Their research has been published in the journal Nature Neuroscience.